| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |